Investor Relations
Our service to analysts, institutional investors and basic investors helps increase Axxess Pharma's market capitalization and enhances our credibility in the financial markets. Our activities focus on maintaining a comprehensive, consistent and topical dialogue between the company and the financial community.
If you have any questions or would like to be included in our mailing database, please contact:
Daniel Bagi M.D., Treasurer
Toll Free Ph# (888) 276-4723
CA Ph# (416) 410-6006
US Ph# (786) 923-0275
Current Financials
Axxess Pharma 1Q2016 Earnings Release
Axxess Pharma 2015 Annual Report
Axxess Pharma 3Q15 Earnings Release
2015 FORM S-1 Registration Statement
Axxess Pharma 2Q15 Earnings Release
Axxess Pharma 1Q15 Earnings Release
Axxess Pharma 2014 Annual Report
- Axxess Pharma 3Q14 Earnings Release
Axxess Pharma 2Q14 Earnings Release
Axxess Pharma 2014 Form S-1 Registration
Axxess Pharma 1Q14 Earnings Release
Axxess Pharma 2013 Annual Report
Axxess Pharma 3Q13 Earnings Release
Axxess Pharma 2Q13 Earnings Release
Axxess Pharma 1Q13 Earnings Release
Axxess Pharma 2012 Annual Report
Quick Links
http://www.axxesspharmainc.com/axxess_tapout.php
Investor Information
For further information, please contact:
Daniel Bagi M.D., Treasurer
Toll Free Ph# (888) 276-4723
CA Ph# (416) 410-6006
US Ph# (786) 923-0275
Follow Axxess